These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18363524)

  • 21. The Clinical Relevance and Therapeutic Benefit of Established Active Ingredients Incorporated into Advanced Foam Vehicles: Vehicle Characteristics Can Influence and Improve Patient Outcomes.
    Del Rosso JQ; Kircik LH; Zeichner J; Stein Gold L
    J Drugs Dermatol; 2019 Feb; 18(2s):s100-s107. PubMed ID: 30811153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Guide to Topical Vehicle Formulations.
    Mayba JN; Gooderham MJ
    J Cutan Med Surg; 2018; 22(2):207-212. PubMed ID: 29137492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compounding is still appropriate in clinical practice.
    Thiers BH
    Dermatol Clin; 1998 Apr; 16(2):329-30. PubMed ID: 9589206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical corticosteroid vehicle composition and implications for clinical practice.
    Oakley R; Arents BWM; Lawton S; Danby S; Surber C
    Clin Exp Dermatol; 2021 Mar; 46(2):259-269. PubMed ID: 33108015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influences of the vehicle in the spreading and release of betamethasone.
    Molesini S; Urto F; Cvetkovska AD; Bettoli V; Valacchi G; Pecorelli A; Manfredini S; Vertuani S
    Ther Deliv; 2018 Feb; 9(3):177-184. PubMed ID: 29424289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical use of systemic drugs in dermatology: a comprehensive review.
    Chiu HY; Tsai TF
    J Am Acad Dermatol; 2011 Nov; 65(5):1048.e1-22. PubMed ID: 21570151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1H NMR spectra of alkane-1,3-diols in benzene: GIAO/DFT shift calculations.
    Lomas JS
    Magn Reson Chem; 2013 Aug; 51(8):469-81. PubMed ID: 23784999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of 2-methyl-2,4-pentane diol (hexylene glycol) in the urine of man and rats.
    JACOBSEN E
    Acta Pharmacol Toxicol (Copenh); 1958; 14(2):195-206. PubMed ID: 13508273
    [No Abstract]   [Full Text] [Related]  

  • 29. The excretion of hexylene glycol (2-methyl-2,4-pentane diol) in man.
    JACOBSEN E
    Acta Pharmacol Toxicol (Copenh); 1958; 14(3):207-13. PubMed ID: 13532730
    [No Abstract]   [Full Text] [Related]  

  • 30. Iatrogenic contact dermatitis and eczematous reactions.
    Angelini G; Vena GA; Grandolfo M; Mastrolonardo M
    Clin Dermatol; 1993; 11(4):467-77. PubMed ID: 8124635
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sensitization to topical corticoids in patients with chronic eczema of the legs].
    Lazzarini S
    AMB Rev Assoc Med Bras; 1979 Apr; 25(4):118-20. PubMed ID: 315593
    [No Abstract]   [Full Text] [Related]  

  • 32. Allergic contact dermatitis to preservatives in topical medicaments.
    Skinner SL; Marks JG
    Am J Contact Dermat; 1998 Dec; 9(4):199-201. PubMed ID: 9810018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products.
    Osborne DW
    J Cosmet Dermatol; 2011 Dec; 10(4):324-9. PubMed ID: 22151944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Topical drug vehicles--influence of galenics in the therapy of atopic eczema].
    Daniels R
    Med Monatsschr Pharm; 2008 Apr; 31(4):139-43. PubMed ID: 18497245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ionic liquids as ingredients in topical drug delivery systems.
    Dobler D; Schmidts T; Klingenhöfer I; Runkel F
    Int J Pharm; 2013 Jan; 441(1-2):620-7. PubMed ID: 23123180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis.
    Saher O; Ghorab DM; Mursi NM
    Pharm Dev Technol; 2016 Aug; 21(5):600-10. PubMed ID: 25886078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric vehicles for topical delivery and related analytical methods.
    Cho HK; Cho JH; Jeong SH; Cho DC; Yeum JH; Cheong IW
    Arch Pharm Res; 2014 Apr; 37(4):423-34. PubMed ID: 24643380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of objective and sensory skin irritations of several cosmetic preservatives.
    Lee E; An S; Choi D; Moon S; Chang I
    Contact Dermatitis; 2007 Mar; 56(3):131-6. PubMed ID: 17295686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional topical delivery systems.
    Weiss SC
    Dermatol Ther; 2011; 24(5):471-6. PubMed ID: 22353153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Unexpected instabilities].
    Wolf G
    Hautarzt; 2013 Jun; 64(6):398-9. PubMed ID: 23914372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.